Cellaria introduces new models to study pancreatic cancer

By The Science Advisory Board staff writers

October 15, 2020 -- Cellaria has launched three new cell lines for pancreatic cancer that it hopes will improve patient care by improving the value of in vitro methods of developing therapies.

The new cell models are called Stew, Chocolate, and Basket, and are linked to specific patient tumor samples and feature different constellations of patient factors such as gender, ethnicity, age, treatment history, and diagnosis. This diversity allows researchers to match their studies with particular patient cohorts, the company said.


Copyright © 2020 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.